Don’t miss the latest developments in business and finance.

Another drug from hospitals found to be of sub-standard quality: Delhi LG

According to officials, another drug sample taken from Delhi government hospitals was failed by the RDTL, or Regional Drug Testing Laboratory, in Chandigarh

pharma, medicine, drugs
Press Trust of India New Delhi
1 min read Last Updated : Dec 27 2023 | 1:48 PM IST

Days after Delhi Lt Governor V K Saxena referred a matter pertaining to drugs failing quality standard tests to CBI, Raj Niwas officials on Wednesday reported another medicine used for treating seizures and epilepsy turning out to be spurious.

Saxena had last week recommended a CBI inquiry into the alleged supply of drugs that "failed quality standard tests" and have the "potential of endangering lives."

According to officials, another drug sample taken from Delhi government hospitals was failed by the RDTL, or Regional Drug Testing Laboratory, in Chandigarh.

This time an anti-epilepsy drug called 'Sodium Valproate' was found to be falling short of the standards.

The report was issued by a government analyst on December 22, an official said.

The drugs that have been found to be of "sub-standard quality" included Cephalexin, a critical life-saving antibiotic used for the treatment of lung and urinary tract infections, according to officials.

They also included Dexamethasone, a steroid used for curing life-threatening inflammation in lungs, joints, and swelling in the body, anti-epilepsy and anti-anxiety psychiatric drug Levetiracetam, and anti-hypertension drug Amlodipine, they said.

Also Read

Topics :Drug makers in Indiadrug manufacturersDrug traffickingdrug testingGovernment hospitalsDelhi government

First Published: Dec 27 2023 | 1:48 PM IST

Next Story